Related Experiment Video
Updated: Jun 15, 2026

Captive Maintenance and Venom Extraction of Tityus serrulatus (Brazilian Yellow Scorpion) for Antivenom Production
Published on: October 6, 2023
Vipera Snakebite in Children: A Focus on Europe
Greta Orlandi1, Nadia Rossi1, Francesco Chiarelli1
1Department of Pediatrics, University of Chieti, 66100 Chieti, Italy.
Insights
European children experiencing snakebites need better management strategies. This review highlights clinical features and treatment of viper envenomation in children, emphasizing the need for validated pediatric tools.
Area of Science:
- Pediatrics
- Toxicology
- Epidemiology
Background:
- Snakebite envenoming is a significant global health issue, with limited recent data on European pediatric cases.
- Children are uniquely vulnerable to venom toxicity due to their lower body mass.
- Current management guidelines for pediatric viper envenomation in Europe lack standardization.
Purpose of the Study:
- To review the clinical characteristics of snake envenomation in European children.
- To summarize current and emerging management strategies for pediatric viper bites.
- To identify gaps in knowledge and highlight the need for validated pediatric clinical tools.
Main Methods:
- This study is a narrative review of existing literature on pediatric snake envenomation in Europe.
- It synthesizes information on epidemiology, clinical presentation, and treatment approaches.
- Focuses on viper envenomation, the most common type in the region.
Main Results:
- Viper envenomation in children primarily presents with local symptoms, but systemic hemotoxic and cytotoxic effects can occur.
- Anti-viper serum immunotherapy is the primary treatment; the roles of antibiotics, steroids, and analgesics remain unclear.
- New tools like VipGrade® exist but require further validation through larger studies.
Conclusions:
- There is a critical need for updated epidemiological data and standardized management protocols for snakebites in European children.
- Further research and validation of pediatric-specific clinical tools are essential for improving patient outcomes.
- Enhanced understanding of viper envenomation in this vulnerable population is crucial.
Abstract:
Although there are over 5 million cases of snakebites each year, up-to-date data on epidemiology and management in European children are lacking in literature. Snakebite envenoming is a rare but potentially life-threatening event, and children are more susceptible due to their lower weight-to-venom ratio. Symptoms of viper envenomation in children are mainly local, but the lymphatic and blood diffusion of the venom may cause systemic symptoms, mainly hemotoxic and cytotoxic symptoms. Immunotherapy with anti-viper serums is the cornerstone of treatment for viper bites, while the use of antibiotics, steroids and analgesics is still unclear and unstandardized. Recently, efforts have been made to improve the pediatric approach to viper envenomation in European children. Several pediatric case reports in children were reported in literature, and a pediatric grading severity score and electronic clinical tool (VipGrade®) were created to better manage this issue. However, larger studies are needed to validate these pediatric tools. This narrative review focuses on the clinical characteristics and management of European snake envenomation in children.
More Related Videos
Related Concept Videos
American Trypanosomiasis
Rabies
Rocky Mountain Spotted Fever
Arboviral Encephalitis
Pharmaceutical Poisoning: Treatment Strategies
Prevention of Further Absorption of Poison

